Related Experiment Videos
Platelet function in chronic liver disease: relationship to disease severity
Digestive Diseases and Sciences
|March 1, 1979
Summary
Chronic liver disease impairs platelet aggregation, linked to liver function, not cause. Smaller platelet volumes suggest larger platelet deficiency may explain defects in patients with liver disease.
Area of Science:
- Hepatology
- Hematology
- Clinical Biochemistry
Background:
- Platelet aggregation is crucial for hemostasis.
- Chronic liver disease (CLD) can affect hemostatic function.
- Adenosine diphosphate (ADP) is a key platelet agonist.
Purpose of the Study:
- To investigate platelet aggregation abnormalities in patients with CLD.
- To correlate these abnormalities with hepatocellular function and disease etiology.
- To explore potential inhibitory or enhancing factors in patient plasma.
Main Methods:
- Studied platelet aggregation in response to ADP in 56 CLD patients.
- Performed cross-over studies using patient platelet-poor plasma.
- Assessed platelet volume and correlated findings with platelet count.
Main Results:
- Platelet aggregation defects correlated with impaired hepatocellular function, irrespective of liver disease etiology.
- Patient plasma contained inhibitors or enhancers of aggregation (e.g., fibrin monomer).
- Severe CLD patients showed intrinsic platelet defects, independent of plasma factors or platelet count, possibly due to smaller platelet volumes.
Conclusions:
- Platelet dysfunction in CLD is linked to hepatocellular function and may involve plasma factors.
- Reduced platelet volume and deficiency of larger platelets might underlie platelet defects in severe CLD.
- Further research into bone marrow or spleen involvement is warranted.